MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Biocept ROCE Ratio 2011-2026 | BIOC
Annual ROCE Ratio Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -360.98 | -6.43 | -44.25 | -189.4 | -585.87 | -779.18 | -565.98 | -226.48 | -269.01 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.43 | -779.18 | -336.4 |
Quarterly ROCE Ratio Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -40.53 | -76.28 | -61.82 | -63.23 | -44.37 | -14.58 | 2.59 | -17.75 | -36.68 | -57.88 | -73.59 | -120.01 | -145.69 | -167.13 | -187.31 | -284.3 | -380.76 | -472.57 | -568.89 | -630.32 | -712.88 | -764.12 | -752.2 | -675.86 | -584.85 | -512.68 | -507.93 | -441.68 | -365.23 | -294.83 | -210.51 | -220.93 | -236.22 | -245.74 | -1600.92 | -1511.08 | -1418.89 | -1345.72 | 66.86 | 49.7 | 30.37 | 15.8 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 66.86 | -1600.92 | -373.35 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 115.19 | 0.1 % | $ 35 B |  USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.14 | 0.44 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.2 | 0.56 % | $ 174 M |  China |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 16.29 | 1.46 % | $ 868 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.41 | 2.92 % | $ 1.88 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 175.38 | -0.17 % | $ 8.69 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 498.64 | 1.04 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 190.7 | 0.6 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.47 | 2.64 % | $ 414 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 122.51 | 1.3 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 7.94 | 3.19 % | $ 1.02 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 14.95 | 3.57 % | $ 452 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 78.76 | 0.2 % | $ 9.87 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.77 | 2.97 % | $ 89.9 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.07 | -3.19 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.27 | -0.12 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 107.75 | 0.88 % | $ 8.89 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 261.97 | 0.4 % | $ 21.8 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 199.83 | 3.52 % | $ 19.7 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 118.95 | 1.55 % | $ 5.56 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.67 | -0.15 % | $ 278 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 80.99 | 0.5 % | $ 5.47 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 192.07 | 0.29 % | $ 21.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.19 | -2.46 % | $ 1.99 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | USA |